Skip to main content

ORIGINAL RESEARCH article

Front. Public Health, 08 January 2024
Sec. Life-Course Epidemiology and Social Inequalities in Health

The relationship between education attainment and gout, and the mediating role of modifiable risk factors: a Mendelian randomization study

Xin Huang&#x;Xin Huang1Xin Chen&#x;Xin Chen2Qixi LiuQixi Liu3Zhiwei ZhangZhiwei Zhang1Juan MiaoJuan Miao3Yuchan LaiYuchan Lai3Jinqing Wu
Jinqing Wu1*
  • 1Department of Orthopedics, Mindong Hospital Affiliated to Fujian Medical University, Fuan, Fujian Province, China
  • 2Department of Urology, Mindong Hospital Affiliated to Fujian Medical University, Fuan, Fujian Province, China
  • 3Department of Nursing, Mindong Hospital Affiliated to Fujian Medical University, Fuan, Fujian Province, China

Objective: To investigate the causal relationship between educational attainment (EA) and gout, as well as the potential mediating effects of individual physical status (IPS) such as body mass index (BMI) and systolic blood pressure (SBP) and lifestyle habits (LH) including alcohol intake frequency (drinking), current tobacco smoking (smoking), and time spent watching television (TV).

Methods: Utilizing two-sample Mendelian randomization (MR), we analyzed the causal effects of EA on gout risk, and of IPS (BMI and SBP) and LH (smoking, drinking, and TV time) on gout risk. Multivariable MR (MVMR) was employed to explore and quantify the mediating effects of IPS and LH on the causal relationship between EA and gout risk.

Results: An elevation of educational attainment by one standard deviation (4.2 years) exhibited a protective effect against gout (odds ratio 0.724, 95% confidence interval 0.552–0.950; p = 0.020). We did not observe a causal relationship between smoking and gout, but BMI, SBP, drinking, and TV time were found to be causal risk factors for gout. Moreover, BMI, SBP, drinking, and TV time acted as mediating factors in the causal relationship between EA and gout risk, explaining 27.17, 14.83, 51.33, and 1.10% of the causal effects, respectively.

Conclusion: Our study indicates that having a genetically predicted higher level of EA may provide protection against gout. We found that this relationship is influenced by IPS factors such as BMI and SBP, as well as LH including drinking and TV time.

1 Introduction

Gout is a widespread inflammatory arthritis characterized by the accumulation of sodium urate crystals in joint and non-articular structures (1). Gout is a chronic condition characterized by intermittent attacks that can severely impact a patient’s joint mobility and overall quality of life (2). These attacks typically target the first metatarsophalangeal joint, resulting in fever, swelling, and excruciating pain that can persist for several days to weeks (3). If left uncontrolled, the condition may progress to involve other joints such as the elbows, wrists, and hands, further exacerbating the patient’s symptoms (4).

Emerging epidemiological evidence highlights the rising prevalence and incidence of gout, shedding light on pressing social issues (5). Gout is a condition that exhibits significant geographic variation in prevalence, with the highest rates observed in Oceania, particularly among indigenous and South Pacific island populations, where the prevalence can exceed 10 percent. In contrast, the prevalence of gout in Europe during the period of 2003–2014 ranged from 1 to 4 percent (6). The pathogenesis of gout is multifactorial, with hyperuricemia being the most significant risk factor for its development (7). Environmental factors, such as the consumption of purine-rich foods, can increase serum uric acid levels, thereby promoting the development of gout (1). Interestingly, previous explorations have shown a hypothetical association between decreased education attainment (EA) and an increased tendency to manifest gout (810). Behaviors and lifestyles play a crucial role in regulating the overall health of the human body (11). Factors such as obesity, high blood pressure, alcohol consumption, smoking, and sedentary behavior have been identified as potential associated factors for gout (7, 1214). The aforementioned IPS (BMI, SBP) and LH (drinking, smoking, TV time) may act as mediators in the association between educational attainment and the onset of gout.

Mendelian randomization (MR) has emerged as a novel genetic epidemiological approach, leveraging genetic variants, such as single-nucleotide polymorphisms (SNPs), as instrumental variables (IVs) to estimate the impact of exposures (i.e., EA) on outcomes (i.e., Gout). The distinctive feature of MR lies in the random allocation of SNPs during pregnancy, unaffected by postnatal factors like lipid levels. Consequently, the biases induced by residual confounding are minimized, and it serves as a bulwark against the confounding and reverse causality issues that are often pervasive in conventional observational studies (15, 16).

Here, we investigated the impact of EA on gout through two-sample MR and investigated the role of IPS and LH in mediating the causal effect of EA on gout risk through multivariable MR (MVMR).

2 Methodology

2.1 Overall study design

The summary data utilized in the MR analyses were obtained from publicly available databases, which had already received ethical approval from the respective studies’ ethics committees (1720). Hence, no additional ethical clearance was required for this MR analysis. The study employed a two-step, two-sample MR design to investigate the potential mediating role of IPS (BMI, SBP) and LH (smoking, drinking, and TV time) in the relationship between EA and gout risk. This study is conducted in three distinct phases. The first phase involves the determination of the causal impact of EA on gout, IPS, and LH. The second phase focuses on establishing the causal influence of IPS and LH on gout. In the third phase, we aim to investigate and quantify the potential mediating role of IPS and LH in the causal relationship between EA and gout.

2.2 Data sources

Education Levels (Self-Reported at Age ≥ 30) were analyzed using data from the Social Science Genetic Association Consortium (SSGAC) database, which includes 766,345 participants of European ancestry (17). The analysis encompassed 10,101,242 SNP data points related to the genetic makeup of individuals with European heritage (further details for each cohort are provided in the Supplementary materials). Each major educational qualification was aligned with the international standard classification of education to derive equivalent years of education. Specifically, one standard deviation represents an additional 4.2 years of education. Population-level data on gout was incorporated from the R5 version of the GWAS conducted by the FinnGen research project.1 This vast dataset involved 150,797 participants of European descent and comprised information on 16,380,152 SNPs. Among this population, there were 3,576 diagnosed cases of gout, with a control group consisting of 147,221 unaffected individuals.

As for GWAS data on potential mediator factors, relevant information was obtained from various consortia. BMI data were sourced from the Genetic Investigation of Anthropometric Traits consortium, encompassing 2,630,552 samples (18). Simultaneously, the International Consortium of Blood Pressure provided data on SBP for 757,601 samples in this study (19). Furthermore, the comprehensive data on current tobacco smoking and alcohol intake frequency were derived from the Medical Research Council Integrative Epidemiology Unit (MRC-IEU). This dataset comprises a substantial cohort of 462,434 and 462,346 individuals of European descent drawn from the UK Biobank, with 9,851,867 of these SNPs associated with current smoking and drinking frequency.2 The UK Biobank represents a monumental prospective cohort study, encompassing approximately half a million adults aged 40 to 69, hailing from 22 centers across the United Kingdom (20). Data concerning time spent watching television were collected by the Neale lab from a study containing 319,740 samples.3 All of the above participants were of European descent and there was no gender discrimination. The exposure data set and the outcome data set are from different databases, and there is no sample overlap. Table 1 gives specifics about the data sources.

TABLE 1
www.frontiersin.org

Table 1. Details of datasets included in analyses.

2.3 SNP selection and quality control

In genetic variation studies aimed at investigating causality, the careful selection of SNPs as IVs and rigorous quality control measures are crucial to ensure the reliability of the findings. The MR analysis in this study is based on three fundamental assumptions (21): (a) strong correlation between IVs and the exposure factor of interest, (b) independence of IVs from confounding factors, and (c) IVs affecting the outcome solely through the exposure. To meet these assumptions, a systematic approach for SNP selection and quality control is followed. Initially, a strict p-value threshold (p < 5 × 10^(−8)) and pairwise linkage disequilibrium (LD) parameters (R squared <0.001 and a clump window >10,000 kB between SNPs) are applied to include only SNPs significantly associated with the exposure variable (22). The strength of each SNP’s effect is assessed by calculating the F-statistic using the formula F = beta^(2)/se^(2), where “beta” represents the effect size of the SNP and “se” represents the corresponding standard error. SNPs with an F-statistic below 10 are excluded to eliminate weakly correlated instruments from further analysis (23). Furthermore, a rigorous filtering process is implemented to systematically exclude palindromic or incompatible SNPs, ensuring the validity and compatibility of the selected IVs. Additionally, to identify and remove any SNPs that may exhibit pleiotropic effects, the MR-Pleiotropy Residual Sum and Outlier (MR-PRESSO) test is employed (24). After this comprehensive screening process, a refined set of SNPs is retained and utilized as IVs in subsequent MR analyses.

2.4 Statistical analysis

A two-step MR approach, a novel method for causal mediation analysis, was employed to investigate the mediating effects of IPS (BMI, SBP) and LH (smoking, drinking, TV time) on the relationship between EA and gout risk. In the first step, the causal effects of education level on BMI, SBP, smoking, drinking, TV time, and gout were estimated through two-sample univariable MR analysis. For the bivariate MR analysis, the inverse-variance weighted (IVW) method with random effects was used as the primary statistical analysis. The IVW method combines the results from each SNP using a random-effects meta-analysis with the multiplication of SNP-specific effects, which is typically the most reliable when the total is valid (25). Supplementary validations were also conducted using MR Egger and weighted median methods (26, 27). The second step involved the utilization of the MVMR method to explore and quantify the potential mediating effects of IPS and LH on the causal relationship between EA and gout (28). Specifically, the estimate of the effect of EA on gout was multiplied by the estimate of the effect of IPS/LH on gout. The total causal effect of EA on gout was then divided by the mediating effect to obtain the IPS/LH-mediated ratio.

To ensure the validity and robustness of the results, various sensitivity analyses were conducted. The heterogeneity of the SNPs used was assessed by performing Cochrane’s Q test, with p-values below 0.05 considered indicative of noteworthy heterogeneity (29). Furthermore, the presence of horizontal pleiotropy was examined by analyzing the intercept obtained through MR Egger analysis, with p-values below 0.05 suggestive of horizontal pleiotropy (16).

The MR analysis was performed using the TwoSampleMR package and MR-PRESSO in R version 4.2.0. The data and code for this study can be obtained from the corresponding author upon reasonable request (Figure 1).

FIGURE 1
www.frontiersin.org

Figure 1. Overview of the study.

3 Result

After rigorous exclusion of SNPs that did not meet strict quality control criteria (p < 5 × 10(−8), R2 < 0.001, F > 10), and subsequent removal of palindromic SNPs and incompatible SNPs, the remaining SNPs were subjected to MR analysis following the implementation of the MR-PRESSO method to mitigate potential outliers. Details of the SNPs can be found in the Supplementary material.

3.1 Overall causal effect of EA on gout, BMI, SBP, and LH

According to the primary IVW method utilized, receive 4.2 years of additional education was associated with a 27.6% lower risk of gout (OR = 0.724, 95% CI = 0.552–0.950, p = 0.020; Figure 2). In addition, a causal relationship between EA and a decrease in BMI, SBP and LH(smoking, drinking and TV time)was established (EA – BMI: OR = 0.837, 95% CI = 0.782–0.896, p = 3.43E-07; EA – SBP: OR = 0.091, 95% CI = 0.053–0.154, p = 9. 10E-19; EA – smoking: OR = 0.854, 95% CI = 0.841–0.867, p = 4.21E-89; EA – drinking: OR = 0.637, 95% CI = 0.608–0.667, p = 9.25E-82; EA-TV time: OR = 0.664, 95% CI = 0.664–0.682, p = 9.62E-205; Figure 2).

FIGURE 2
www.frontiersin.org

Figure 2. Forest plot displays the results of univariable MR analyses. MR, Mendelian randomization; het, heterogeneity; pleio, pleiotropy; IVW, inverse-variance weighted; EA, education attainment; BMI, body mass index; SBP, systolic blood pressure.

3.2 Overall causal effects of BMI, SBP, and LH on gout

Utilizing the IVW method, it was observed that higher BMI, SBP, drinking, and longer TV time were causally associated with an increased risk of developing gout (BMI-Gout: OR = 1.709, 95% CI = 1.227–2.381, p = 0.002; SBP-Gout: OR = 1.020, 95% CI = 1.009–1.031, p = 2.29E-04; driking-Gout: OR = 1.454, 95% CI = 1.025–2.061, p = 0.036; TV time-Gout: OR = 2.968, 95% CI = 1.525–5.776, p = 0.001; Figure 2). However, the analysis did not reveal a causal relationship between smoking and gout (smoking-Gout: OR = 0.838, 95% CI = 0.243–2.891, p = 0.780; Figure 2).

3.3 Mediating effect of BMI, SBP and LH on EA and gout

Although a causal relationship between smoking and gout was not observed, it was identified that education level had a causal impact on BMI, SBP, drinking, and TV time, and these factors also demonstrated causal effects on gout risk. Therefore, it was hypothesized that, excluding smoking, these four IPS and LH factors served as mediators in the connection between education level and gout risk. Subsequently, further analyses were conducted to evaluate the mediating effect of these four factors on the association between EA and gout risk.

After adjusting for EA, it was observed that higher BMI was linked to a 54.8% increase in the risk of gout (OR = 1.548, 95% CI = 1.142–2.097, p = 0.005; Figure 3). Therefore, the mediating effect of BMI on the causal relationship between EA and gout risk was estimated at 27.17%. Moreover, after adjusting for EA, higher SBP was associated with a 2.1% increase in gout risk (OR = 1.021, 95% CI = 1.009–1.033, p = 0.001; Figure 3), suggesting that SBP mediated 14.83% of the causal effect between EA and gout risk. Additionally, adjusting for EA revealed that higher drinking led to a 47.2% increase in gout risk (OR = 1.472, 95% CI = 1.037–2.090, p = 0.031; Figure 3), indicating that drinking mediated 51.33% of the causal effect between EA and gout risk. Furthermore, after adjusting for EA, TV time was associated with a 150.5% increase in gout risk (OR = 2.504, 95% CI = 0.950–6.599, p = 0.063; Figure 3), signifying that TV time mediated 1.10% of the causal effect between EA and gout risk.

FIGURE 3
www.frontiersin.org

Figure 3. Forest plot denotes the results of multivariable MR analyses. MR, Mendelian randomization; IVW, inverse-variance weighted; EA, education attainment; BMI, body mass index; SBP, systolic blood pressure.

3.4 Sensitivity analysis

Finally, sensitivity analyses were carried out employing weighted median regression and MR-Egger methods, yielding estimates with analogous trends but diminished confidence levels (Figure 2). The heterogeneity among the included SNPs was assessed through the utilization of Cochran’s Q statistic within the IVW and MR-Egger models. The findings revealed the presence of potential heterogeneity in the majority of analyses (Figure 2). Nonetheless, it is noteworthy that this phenomenon was deemed acceptable, given that the principal outcomes were predicated upon the utilization of the random-effects IVW methodology (30). Additionally, MR-Egger regression intercepts did not indicate horizontal pleiotropy, suggesting that the current MR analysis was not influenced by such bias (p > 0.05; Figure 2).

4 Discussion

Results of our two-sample MR study suggest that to receive 4.2 years of additional education is associated with a reduced risk of gout. In addition, our rigorous MVMR and mediation analysis revealed the interesting role of elevated BMI, increased SBP, increased drinking, and extended TV time as mediating factors, depicting causal trajectories from EA to gout manifestations. This nuanced understanding has profound implications for constructing a mechanistic blueprint linking behavioral and metabolic risk factors to gout, effectively guiding prevention and treatment efforts against this urate crystal-driven inflammatory arthritis. Of these clear causal relationships, drinking appears to be the most important, accounting for an estimated 51.33% of the total effect of EA on gout. In contrast, BMI mediated 27.17%, SBP 14.83%, and TV time mediated 1.10%. Interestingly, our study did not consider smoking as a contributing factor to the development of gout due to differences in educational levels.

Inequality in EA remains a persistent social challenge implicitly linked to socio-economic and individual poverty (31). Historically, studies have shown that poor educational achievement is a potential catalyst for gout attacks (9, 10). Our survey is consistent with this view, documenting a clear negative correlation between EA and gout prevalence. Outstanding educational achievements often equip individuals with the awareness and improved living conditions necessary for a healthy lifestyle, thus decisively preventing the manifestations of gout (3234). In addition, for those patients with gout, higher education can improve their ability to comply with health care guidelines and manage their personal life environment, thereby suppressing gout recurrence (35, 36). A revealing meta-analysis showed that of all inflammatory arthritis diseases, patients with gout had the highest rate of treatment non-adherence, reaching a staggering 90% (37). Another study conducted by Gisele Zandman-Goddard et al. revealed that of the 7,644 gout patients surveyed in Israel, only one in six adhered to allopurinol treatment (38). Higher levels of education may be an effective lever to improve medical adherence, which in turn improves the quality of life of people with gout (39).

Existing research suggests that the manifestation of gout is closely related to an individual’s physical health parameters, such as high blood pressure and obesity, which in turn are related to an individual’s EA (12, 4043). The results of a previous survey suggest that people with high blood pressure have a two-to three-fold higher risk of developing gout (44). Elevated SBP has been shown in many studies to be a predictor of hyperuricaemia and careful SBP management has a positive effect on reducing the incidence of gout (4547). Natalie McCormick et al. described a causal relationship between obesity and gout in a focused cohort study. The hypothesis is that without targeted weight loss, the risk of gout in obese men persists, even with other mitigation measures such as abstinence from alcohol, adherence to high DASH scores, and avoidance of diuretics (48). Our study reinforces the assertions of these previous explorations. Through MVMR analysis, this study determined that SBP and BMI mediated the occurrence of gout due to low EA by 14.83 and 27.17%, respectively. These findings suggest that lowering BMI and preventing hypertensive disorders can be effective strategies to stop gout attacks, especially in less educated people. Therefore, maintaining optimal IPS, such as proper weight range and normal blood pressure, plays an important role in preventing gout.

Previous surveys have consistently highlighted the strong link between EA and LH, including drinking, smoking and physical activity (32, 49, 50). These factors are inevitably intertwined with the onset of gout (5153). Recent analysis by Lin Han et al. To determine that chronic and excessive alcohol consumption is a key predictor of tophi and subcutaneous tophi manifestations in patients with gout. In addition, their report linked weekly alcohol consumption to tophi progression in individuals who already had speculative tophi (54). These findings were corroborated by a study conducted by Tuhina Neogi et al., which demonstrated that the risk of gout recurrence was elevated irrespective of the type of alcoholic beverage consumed, and was linked to occasional alcohol intake (55). Consistent with these observations, our findings suggest that drinking is associated with EA and has an impact on gout prevalence—a relationship estimated to account for 51.33% of the genetic factor’s influence on disease progression. Similarly, physical activity is becoming an important mechanism for preventing gout (34). Increased TV time means less time spent on physical health, and our calculations show that TV time contributes 1.10% to education-mediated gout progression. These findings strongly suggest that adopting a healthier LH – based on curbing excessive alcohol consumption and promoting physical activity – constitutes an important prevention strategy to reduce the incidence of gout in people with lower levels of education.

Over time, the so-called causal relationship between smoking and gout remains a hotly debated topic (56). Various observational studies have come to different conclusions; While some believe that smoking may reduce the incidence of gout, others categorically deny that smoking has any substantial effect on gout (14, 51, 57). Early two-way Mendelian randomization studies confirmed the lack of a causal relationship between smoking and gout, adding weight to the latter position (58). Our empirical evidence echoes these conclusions, and our data show that smoking does not mediate the relationship between educational attainment and gout prevalence. Therefore, it is reasonable to assume that smoking has no effect on preventing gout.

Our survey, while illuminating, also acknowledges certain limitations. Initially, despite the robustness of our MR study, this research could not completely rule out the possibility of horizontal pleiotropy or other direct causal pathways. Nevertheless, the authenticity of our method is supported by interceptions from our validated MR-Egger regression analysis, indicating that there is no evidence of universal horizontal pleiotropy. Second, the GWAS database this study used primarily categorizes individuals of European ancestry, which may inevitably limit the broad applicability of our findings to populations of different ancestry. This inherent bias may have implications for the generalizability of our findings. Third, while this study utilized multivariate MR to examine the mediators and their respective mediating proportions of educational attainment inequality on gout occurrence, it is important to note that these mediating proportions may interact with one another, and the joint proportions after accounting for this interaction have yet to be quantified.

5 Conclusion

This study provides evidence of a causal relationship between lower levels of education and increased rates of gout. Drinking accounted for a large proportion of this effect, regulating 51.33% of the association. BMI became another important mediating variable, explaining 27.17% of the total effect. In addition, SBP plays a significant mediating role, accounting for 14.83%. Therefore, for individuals with limited access to educational resources, adopting strategies such as moderating alcohol intake and incorporating regular exercise into their routine to maintain a healthy body mass index and blood pressure may prove effective in preventing gout.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author.

Ethics statement

Ethical approval was not required for the studies involving humans because the ethical review and approval for the original studies are available in the respective publications. Informed consent was obtained from all participants involved in the original genome-wide association studies. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

XH: Project administration, Writing – review & editing, Conceptualization, Formal Analysis, Methodology, Resources, Software, Visualization, Writing – original draft. XC: Resources, Software, Visualization, Writing – original draft, Data curation, Formal analysis, Methodology. QL: Funding acquisition, Project administration, Resources, Supervision, Validation, Writing – review & editing. ZZ: Formal analysis, Investigation, Methodology, Resources, Software, Writing – original draft. JM: Resources, Supervision, Validation, Writing – review & editing. YL: Resources, Supervision, Validation, Writing – review & editing. JW: Funding acquisition, Project administration, Resources, Supervision, Writing – review & editing.

Funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Acknowledgments

The authors express their sincere gratitude to the researchers who generously provided the original dataset used in this study.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpubh.2023.1269426/full#supplementary-material

Footnotes

References

1. Dalbeth, N, Gosling, AL, Gaffo, A, and Abhishek, A. Gout. Lancet. (2021) 397:1843–55. doi: 10.1016/S0140-6736(21)00569-9

CrossRef Full Text | Google Scholar

2. Zhang, Y, Chen, S, Yuan, M, Xu, Y, and Xu, H. Gout and diet: a comprehensive review of mechanisms and management. Nutrients. (2022) 14:3525. doi: 10.3390/nu14173525

CrossRef Full Text | Google Scholar

3. Dalbeth, N, Merriman, TR, and Stamp, LK. Gout. Lancet. (2016) 388:2039–52. doi: 10.1016/S0140-6736(16)00346-9

CrossRef Full Text | Google Scholar

4. Liang, X, Cai, J, and Fan, Y. Causal association between tea intake and risk for gout: a Mendelian randomization study. Front Genet. (2023) 14:1220931. doi: 10.3389/fgene.2023.1220931

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Singh, JA, and Gaffo, A. Gout epidemiology and comorbidities. Semin Arthritis Rheum. (2020) 50:S11–6. doi: 10.1016/j.semarthrit.2020.04.008

CrossRef Full Text | Google Scholar

6. Dehlin, M, Jacobsson, L, and Roddy, E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. (2020) 16:380–90. doi: 10.1038/s41584-020-0441-1

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Ragab, G, Elshahaly, M, and Bardin, T. Gout: an old disease in new perspective – a review. J Adv Res. (2017) 8:495–511. doi: 10.1016/j.jare.2017.04.008

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Bowen-Davies, Z, Muller, S, Mallen, CD, Hayward, RA, and Roddy, E. Gout severity, socioeconomic status, and work absence: a cross-sectional study in primary care. Arthritis Care Res (Hoboken). (2018) 70:1822–8. doi: 10.1002/acr.23562

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Kiadaliri, A, Moreno-Betancur, M, Turkiewicz, A, and Englund, M. Educational inequalities in all-cause and cause-specific mortality among people with gout: a register-based matched cohort study in southern Sweden. Int J Equity Health. (2019) 18:164. doi: 10.1186/s12939-019-1076-1

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Kapetanovic, MC, Hameed, M, Turkiewicz, A, Neogi, T, Saxne, T, Jacobsson, L, et al. Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective. RMD Open. (2016) 2:e000326. doi: 10.1136/rmdopen-2016-000326

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Stephens, CR, Easton, JF, Robles-Cabrera, A, Fossion, R, de la Cruz, L, Martínez-Tapia, R, et al. The impact of education and age on metabolic disorders. Front Public Health. (2020) 8:8. doi: 10.3389/fpubh.2020.00180

CrossRef Full Text | Google Scholar

12. Cao, Z, Xu, C, Zhang, P, and Wang, Y. Associations of sedentary time and physical activity with adverse health conditions: outcome-wide analyses using isotemporal substitution model. EClinicalMedicine. (2022) 48:101424. doi: 10.1016/j.eclinm.2022.101424

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Teramura, S, Yamagishi, K, Umesawa, M, Hayama-Terada, M, Muraki, I, Maruyama, K, et al. Risk factors for Hyperuricemia or gout in men and women: the circulatory risk in communities study (CIRCS). J Atheroscler Thromb. (2023) 30:1483–91. doi: 10.5551/jat.63907

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Gee Teng, G, Pan, A, Yuan, JM, and Koh, WP. Cigarette smoking and the risk of incident gout in a prospective cohort study. Arthritis Care Res (Hoboken). (2016) 68:1135–42. doi: 10.1002/acr.22821

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Sekula, P, del Greco M, F, Pattaro, C, and Köttgen, A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. (2016) 27:3253–65. doi: 10.1681/ASN.2016010098

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Bowden, J, Davey Smith, G, and Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression. Int J Epidemiol. (2015) 44:512–25. doi: 10.1093/ije/dyv080

PubMed Abstract | CrossRef Full Text | Google Scholar

17. 23andMe Research TeamCOGENT (Cognitive Genomics Consortium)Social Science Genetic Association ConsortiumLee, JJ, Wedow, R, Okbay, A, et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat Genet. (2018) 50:1112–21. doi: 10.1038/s41588-018-0147-3

PubMed Abstract | CrossRef Full Text | Google Scholar

18. The LifeLines Cohort Study, The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The GLGC, The ICBP, The MAGIC Investigators, The MuTHER Consortium, The MIGen Consortium, The PAGE Consortium, The ReproGen Consortium, The GENIE Consortium, The International Endogene ConsortiumLocke, AE, Kahali, B, Berndt, SI, Justice, AE, Pers, TH, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. (2015) 518:197–206. doi: 10.1038/nature14177

PubMed Abstract | CrossRef Full Text | Google Scholar

19. the Million Veteran ProgramEvangelou, E, Warren, HR, Mosen-Ansorena, D, Mifsud, B, Pazoki, R, et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet. (2018) 50:1412–25. doi: 10.1038/s41588-018-0205-x

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Sudlow, C, Gallacher, J, Allen, N, Beral, V, Burton, P, Danesh, J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. (2015) 12:e1001779. doi: 10.1371/journal.pmed.1001779

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Lawlor, DA. Commentary: two-sample Mendelian randomization: opportunities and challenges. Int J Epidemiol. (2016) 45:908–15. doi: 10.1093/ije/dyw127

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Pierce, BL, Ahsan, H, and Vanderweele, TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. (2011) 40:740–52. doi: 10.1093/ije/dyq151

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Hartwig, FP, Davies, NM, Hemani, G, and Davey Smith, G. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int J Epidemiol. (2016) 45:1717–26. doi: 10.1093/ije/dyx028

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Verbanck, M, Chen, CY, Neale, B, and do, R. Publisher correction: detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. (2018) 50:1196. doi: 10.1038/s41588-018-0164-2

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Burgess, S, Bowden, J, Fall, T, Ingelsson, E, and Thompson, SG. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology. (2017) 28:30–42. doi: 10.1097/EDE.0000000000000559

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Bowden, J, Davey Smith, G, Haycock, PC, and Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. (2016) 40:304–14. doi: 10.1002/gepi.21965

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Burgess, S, and Thompson, SG. Interpreting findings from Mendelian randomization using the MR-egger method. Eur J Epidemiol. (2017) 32:377–89. doi: 10.1007/s10654-017-0255-x

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Carter, AR, Sanderson, E, Hammerton, G, Richmond, RC, Davey Smith, G, Heron, J, et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. (2021) 36:465–78. doi: 10.1007/s10654-021-00757-1

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Burgess, S, Dudbridge, F, and Thompson, SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med. (2016) 35:1880–906. doi: 10.1002/sim.6835

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Burgess, S, Butterworth, A, and Thompson, SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. (2013) 37:658–65. doi: 10.1002/gepi.21758

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Zhao, SS, Holmes, MV, Zheng, J, Sanderson, E, and Carter, AR. The impact of education inequality on rheumatoid arthritis risk is mediated by smoking and body mass index: Mendelian randomization study. Rheumatology (Oxford). (2022) 61:2167–75. doi: 10.1093/rheumatology/keab654

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Kari, JT, Viinikainen, J, Böckerman, P, Tammelin, TH, Pitkänen, N, Lehtimäki, T, et al. Education leads to a more physically active lifestyle: evidence based on Mendelian randomization. Scand J Med Sci Sports. (2020) 30:1194–204. doi: 10.1111/sms.13653

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Atella, V, and Kopinska, J. Body weight, eating patterns, and physical activity: the role of education. Demography. (2014) 51:1225–49. doi: 10.1007/s13524-014-0311-z

CrossRef Full Text | Google Scholar

34. Zhang, Y, Yang, R, Dove, A, Li, X, Yang, H, Li, S, et al. Healthy lifestyle counteracts the risk effect of genetic factors on incident gout: a large population-based longitudinal study. BMC Med. (2022) 20:138. doi: 10.1186/s12916-022-02341-0

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Vaccher, S, Kannangara, DRW, Baysari, MT, Reath, J, Zwar, N, Williams, KM, et al. Barriers to Care in Gout: from prescriber to patient. J Rheumatol. (2016) 43:144–9. doi: 10.3899/jrheum.150607

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Rai, SK, Choi, HK, Choi, SHJ, Townsend, AF, Shojania, K, and de Vera, MA. Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies. Rheumatology (Oxford). (2018) 57:1282–92. doi: 10.1093/rheumatology/kex530

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Campbell, NKJ, Saadeldin, K, and De Vera, MA. The duality of economic issues with medication non-adherence in patients with inflammatory arthritis. Curr Rheumatol Rep. (2017) 19:66. doi: 10.1007/s11926-017-0691-3

CrossRef Full Text | Google Scholar

38. Zandman-Goddard, G, Amital, H, Shamrayevsky, N, Raz, R, Shalev, V, and Chodick, G. Rates of adherence and persistence with allopurinol therapy among gout patients in Israel. Rheumatology (Oxford). (2013) 52:1126–31. doi: 10.1093/rheumatology/kes431

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Guo, G, Dong, C, Yin, R, Yang, Y, Zhao, R, Wang, Y, et al. Serum urate goal attainment and associated factors in Chinese gout patients. Psychol Health Med. (2020) 25:931–9. doi: 10.1080/13548506.2019.1706751

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Rai, SK, Fung, TT, Lu, N, Keller, SF, Curhan, GC, and Choi, HK. The dietary approaches to stop hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study. BMJ. (2017) 357:j1794. doi: 10.1136/bmj.j1794

CrossRef Full Text | Google Scholar

41. Pan, A, Teng, GG, Yuan, JM, and Koh, WP. Bidirectional association between self-reported hypertension and gout: the Singapore Chinese health study. PLoS One. (2015) 10:e0141749. doi: 10.1371/journal.pone.0141749

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Wang, Y, Ye, C, Kong, L, Zheng, J, Xu, M, Xu, Y, et al. Independent associations of education, intelligence, and cognition with hypertension and the mediating effects of Cardiometabolic risk factors: a Mendelian randomization study. Hypertension. (2023) 80:192–203. doi: 10.1161/HYPERTENSIONAHA.122.20286

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Witkam, R, Gwinnutt, JM, Humphreys, J, Gandrup, J, Cooper, R, and Verstappen, SMM. Do associations between education and obesity vary depending on the measure of obesity used? A systematic literature review and meta-analysis. SSM Popul Health. (2021) 15:100884. doi: 10.1016/j.ssmph.2021.100884

PubMed Abstract | CrossRef Full Text | Google Scholar

44. McAdams-DeMarco, MA, Maynard, JW, Baer, AN, and Coresh, J. Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort. J Clin Hypertens (Greenwich). (2012) 14:675–9. doi: 10.1111/j.1751-7176.2012.00674.x

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Yang, Y, Xian, W, Wu, D, Huo, Z, Hong, S, Li, Y, et al. The role of obesity, type 2 diabetes, and metabolic factors in gout: a Mendelian randomization study. Front Endocrinol (Lausanne). (2022) 13:917056. doi: 10.3389/fendo.2022.917056

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Lu, J, Sun, W, Cui, L, Li, X, He, Y, Liu, Z, et al. A cross-sectional study on uric acid levels among Chinese adolescents. Pediatr Nephrol. (2020) 35:441–6. doi: 10.1007/s00467-019-04357-w

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Sun, M, Vazquez, AI, Reynolds, RJ, Singh, JA, Reeves, M, Merriman, TR, et al. Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities. Arthritis Res Ther. (2018) 20:90. doi: 10.1186/s13075-018-1558-3

PubMed Abstract | CrossRef Full Text | Google Scholar

48. McCormick, N, Rai, SK, Lu, N, Yokose, C, Curhan, GC, and Choi, HK. Estimation of primary prevention of gout in men through modification of obesity and other key lifestyle factors. JAMA Netw Open. (2020) 3:e2027421. doi: 10.1001/jamanetworkopen.2020.27421

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Zhou, T, Sun, D, Li, X, Ma, H, Heianza, Y, and Qi, L. Educational attainment and drinking behaviors: Mendelian randomization study in UK biobank. Mol Psychiatry. (2021) 26:4355–66. doi: 10.1038/s41380-019-0596-9

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Tchicaya, A, Lorentz, N, and Demarest, S. Socioeconomic inequalities in smoking and smoking cessation due to a smoking ban: general population-based cross-sectional study in Luxembourg. PLoS One. (2016) 11:e0153966. doi: 10.1371/journal.pone.0153966

CrossRef Full Text | Google Scholar

51. Wang, W, and Krishnan, E. Cigarette smoking is associated with a reduction in the risk of incident gout: results from the Framingham heart study original cohort. Rheumatology (Oxford). (2015) 54:91–5. doi: 10.1093/rheumatology/keu304

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Jee, YH, Jung, KJ, Park, YB, Spiller, W, and Jee, SH. Causal effect of alcohol consumption on hyperuricemia using a Mendelian randomization design. Int J Rheum Dis. (2019) 22:1912–9. doi: 10.1111/1756-185X.13668

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Chen, JH, Wen, CP, Wu, SB, Lan, JL, Tsai, MK, Tai, YP, et al. Attenuating the mortality risk of high serum uric acid: the role of physical activity underused. Ann Rheum Dis. (2015) 74:2034–42. doi: 10.1136/annrheumdis-2014-205312

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Han, L, Li, R, Lu, J, Ren, W, Ning, C, Pang, J, et al. Association of the Quantity, duration, and type of alcohol consumption on the development of gouty tophi. Arthritis Care Res (Hoboken). (2023) 75:1079–87. doi: 10.1002/acr.24968

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Neogi, T, Chen, C, Niu, J, Chaisson, C, Hunter, DJ, and Zhang, Y. Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study. Am J Med. (2014) 127:311–8. doi: 10.1016/j.amjmed.2013.12.019

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Fanning, N, Merriman, TR, Dalbeth, N, and Stamp, LK. An association of smoking with serum urate and gout: a health paradox. Semin Arthritis Rheum. (2018) 47:825–42. doi: 10.1016/j.semarthrit.2017.11.004

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Jee, Y, Jeon, C, Sull, JW, Go, E, and Cho, SK. Association between smoking and gout: a meta-analysis. Clin Rheumatol. (2018) 37:1895–902. doi: 10.1007/s10067-018-4118-y

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Lee, YH. Assessing the causal association between smoking behavior and risk of gout using a Mendelian randomization study. Clin Rheumatol. (2018) 37:3099–105. doi: 10.1007/s10067-018-4210-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Glossary

Keywords: education attainment, gout, mediation, Mendelian randomization study, causal relationship

Citation: Huang X, Chen X, Liu Q, Zhang Z, Miao J, Lai Y and Wu J (2024) The relationship between education attainment and gout, and the mediating role of modifiable risk factors: a Mendelian randomization study. Front. Public Health. 11:1269426. doi: 10.3389/fpubh.2023.1269426

Received: 03 August 2023; Accepted: 14 December 2023;
Published: 08 January 2024.

Edited by:

Ozgur Karcioglu, Taksim Training and Research Hospital, Türkiye

Reviewed by:

Fazleen Izzany Abu Bakar, Universiti Tun Hussein Onn Malaysia, Malaysia
Ruben Yvan Maarten Fossion, National Autonomous University of Mexico, Mexico

Copyright © 2024 Huang, Chen, Liu, Zhang, Miao, Lai and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jinqing Wu, wujinqingjy@163.com

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.